Advertisement
Home »

Thymoquinone, piperine, and sorafenib combinations attenuate liver and breast cancers progression: epigenetic and molecular docking approaches.

Mar 06, 2023

REFERENCES & ADDITIONAL READING

PubMed

ABOUT THE CONTRIBUTORS

  • Ashraf A El-Shehawy

    Department of Chemistry, Faculty of Science, Kafrelsheikh University, Kafrelsheikh, 33516, Egypt.

    Alaa Elmetwalli

    Department of Clinical Trial Research Unit and Drug Discovery, Egyptian Liver Research Institute and Hospital (ELRIAH), Mansoura, Egypt. dr.prof2011@gmail.com.

    Ali H El-Far

    Department of Biochemistry, Faculty of Veterinary Medicine, Damanhour University, Damanhour, 22511, Egypt.

    Sahar Abd El-Razik Mosallam

    Zoology Department, Women’s College for Arts, Science and Education, Ain Shams University, Cairo, Egypt.

    Afrah Fatthi Salama

    Biochemistry Section, Chemistry Department, Faculty of Science, Tanta University, Tanta, 31527, Egypt. afrahsalama@yahoo.com.

    Ahmad O Babalghith

    Medical Genetics Department, College of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia.

    Mohammad A Mahmoud

    Department of Chemistry, Faculty of Science, Kafrelsheikh University, Kafrelsheikh, 33516, Egypt.

    Hany Mohany

    Department of Chemistry, Faculty of Science, Kafrelsheikh University, Kafrelsheikh, 33516, Egypt.

    Mohamed Gaber

    Chemistry Department, Faculty of Science, Tanta University, Tanta, 31527, Egypt.

    Tarek El-Sewedy

    Department of Applied Medical Chemistry, Medical Research Institute, Alexandria University, Alexandria, Egypt.

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


EXPLORE MORE

Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RELEVANT ARTICLES FOR YOU

Advertisement